Restricted accessCase reportFirst published online 2018-4
Facial and limb angioedema with parotitis and Kikuchi-like necrotizing lymphadenitis preceding neuropsychiatric systemic lupus erythematosus in a young African American male
Angioedema has been observed in a few cases secondary to systemic lupus erythematosus (SLE). Herein, we report a rare case where a young healthy male initially presented with angioedema, lymphadenopathy and parotitis and later on developed neuropsychiatric manifestations at the very onset of his SLE disease. This case illustrates the importance of prompt clinical consideration of lupus with unusual and atypical preceding manifestations
MarkovicSNInwardsDJFrigasEAPhylikyRP. Acquired C1esterase inhibitor deficiency. Ann Intern Med2000; 132: 144–150.
2.
CacoubPFrémeaux-BacchiVDe LacroixIet al.A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Arthritis Rheum2001; 44: 1836–1840.
3.
NakamuraSYoshinariMSakuYet al.Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system. Ann Rheum Dis1991; 50: 713–716.
4.
BienstockDMandelL. Facial angioedema and systemic lupus erythematosus: Case report. J Oral Maxillofac Surg2015; 73: 928–932.
5.
Gómez CaballeroMEMartínez-MorilloM. A woman with systemic lupus erythematosus and polyadenopathy. Rheumatol Clin2013; 9: 188–192.
6.
SantanaALessaBGalrãoLLimaISantiagoM. Kikuchi-Fujimoto’s disease associated with systemic lupus erythematosus: Case report and review of the literature. Clin Rheumatol2005; 24: 60–63.
7.
Sopeña B, Rivera A, Chamorro A, et al. Clinical association between Kikuchi’s disease and systemic lupus erythematosus: A systematic literature review. Semin Arthritis Rheum 2017; 47: 46–52.
8.
Ficko C, Andriamanantena D, Dumas G, et al. Kikuchi’s disease: An unusual cause of lymphocytic meningitis. Rev Neurol (Paris) 2013; 169: 912–913.
9.
CramerJSchmiedelSAlegreNGSchäferHBurchardGDMerzH. Necrotizing lymphadenitis: Kikuchi-Fujimoto disease alias lupus lymphadenitis?Lupus2010; 19: 89–92.
10.
KimSKKangMSYoonBYet al.Histiocytic necrotizing lymphadenitis in the context of systemic lupus erythematosus (SLE): Is histiocytic necrotizing lymphadenitis in SLE associated with skin lesions?Lupus2011; 20: 809–819.
11.
HuSKuoTTHongHS. Lupus lymphadenitis simulating Kikuchi’s lymphadenitis in patients with systemic lupus erythematosus: A clinicopathological analysis of six cases and review of the literature. Pathol Int2003; 53: 221–226.
12.
DuboisELTuffanelliDL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 20 cases. JAMA1964; 190: 104–111.
13.
McCuneWJGolbusJ. Neuropsychiatric lupus. Rheum Dis Clin North Am1988; 14: 149–167.
14.
JosephFGLammieGAScoldingNJ. CNS lupus: A study of 41 patients. Neurology2007; 69: 644–654.
15.
KampylafkaEIAlexopoulosHFoukaPMoutsopoulosHMDalakasMCTzioufasAG. Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations. Lupus2016; 25: 1260–1265.
16.
Magro-ChecaCZirkzeeEJHuizingaTWSteup-BeekmanGM. Management of neuropsychiatric systemic lupus erythematosus: Current approaches and future perspectives. Drugs2016; 76: 459–483.
17.
PetriM. Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody positive patients. Curr Rheumatol Rep2011; 13: 77–80.
18.
OmdalRMellgrenSIHusbyG. Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus. Scand J Rheumatol1988; 17: 113–117.
